Progressive multifocal leukoencephalopathy in a patient with glioblastoma

J Neurooncol. 2011 Jul;103(3):791-6. doi: 10.1007/s11060-010-0453-9. Epub 2010 Dec 1.

Abstract

Malignant gliomas are aggressive malignancies which inevitably recur despite multimodality treatment. In a subset of patients who are longer term survivors of this disease, progressive radiologic worsening can also occur from late effects of radiation rather than recurrent tumor, a differential diagnosis that is commonly considered in this setting. However, other causes for radiologic progression are not as well recognized and could potentially confound management leading to incorrect treatment decisions. Progressive multifocal leukoencephalopathy (PML) is a rare infectious demyelinating disease of the central nervous system seen primarily in immunocompromised patients, the early diagnosis and treatment of which remains a challenge. Here, we report a case of a long term survivor with glioblastoma whose diagnostic and therapeutic management was confounded by the development of PML. We review the radiological features and clinical course of this patient to highlight the dramatic neurological course in the setting of a highly malignant tumor, and emphasize the unusual changes in diffusion weighted images, and the need for clinical suspicion for early diagnosis of PML.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents, Alkylating / therapeutic use
  • Brain Neoplasms / complications*
  • Corpus Callosum / pathology
  • Disease Progression
  • Electroencephalography
  • Frontal Lobe / pathology
  • Glioblastoma / complications*
  • Humans
  • Leukoencephalopathy, Progressive Multifocal / diagnosis
  • Leukoencephalopathy, Progressive Multifocal / etiology*
  • Leukoencephalopathy, Progressive Multifocal / therapy
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged

Substances

  • Antineoplastic Agents, Alkylating